We're #hiring a new Director, Plant Controller in East Windsor, New Jersey. Apply today or share this post with your network.
ANI Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Princeton, New Jersey 17,660 followers
Serving Patients, Improving Lives
About us
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
- Website
-
http://www.anipharmaceuticals.com/
External link for ANI Pharmaceuticals, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Princeton, New Jersey
- Type
- Public Company
- Specialties
- Hormone Manufacturing and Packaging, Solid Dose Manufacturing and Packaging, Contract Packaging, Liquid Dose Manufacturing and Packaging, Controlled Substances, Rare Disease, Generics, Established Brands, Contract Manufacturing, Oncolytics, and Cortrophin
Locations
-
Primary
500 Alexander Park
Princeton, New Jersey 08540, US
-
210 Main Street W
Baudette, MN 56623, US
-
70 Lake Dr
East Windsor, New Jersey 08520, US
-
SIDCO Muti-Story Complex, SIDCO Industrial Estate
Module 20, 2nd Floor, Thirumazhisai
Chennai, Thiruvallur District 600124, IN
Employees at ANI Pharmaceuticals, Inc.
Updates
-
We're #hiring a new Manufacturing Operator in East Windsor, New Jersey. Apply today or share this post with your network.
-
Did you know that #chronicdiseases are the leading cause of disability and death in the US? These conditions come with challenges that extend beyond the physical symptoms, requiring ongoing care and management. Today, we recognize #ChronicDiseaseDay in support of the millions of people impacted by chronic illness. We believe that by raising awareness together, we can create a future where chronic diseases are managed more effectively and patients can lead healthier, more fullling lives. #ANIP
-
Recently, ANI team members had the privilege of attending the EULAR - European Alliance of Associations for Rheumatology 2024 Congress in Vienna, Austria. This premier event brought together patients, healthcare professionals, and industry partners from around the world to share the latest insights and advancements that are shaping the future of #rheumatology. We enjoyed engaging with thought leaders and discussing improving the care and management of rheumatic disease. Our on-site team included Michael J. Dittbenner (Executive Director, SD&A, U.S. Rare Disease), Jason James, MBA (Director, SD&A, Rare Disease), and Grace Hsueh, PharmD from our medical affairs team. Also pictured: members of the Association of Women in Rheumatology (AWIR). Many thanks to EULAR for hosting such an inspiring and informative event. We look forward to attending AWIR’s Annual Conference this month! #ANIP #raredisease #pharmaceuticals
-
This July 4th, we reflect on the values of liberty and innovation that inspire the entire ANI team. Across the USA, our diverse workforce collaborates across borders to advance our mission of “Serving Patient & Improving Lives.” As we celebrate America's independence, we're thankful for the freedoms and opportunities that fuel progress worldwide. To our US team, happy Independence Day, and to all our colleagues around the globe, thank you for your dedication! #July4th #pharmaceuticals #ANIP
-
ANI Pharmaceuticals, Inc. reposted this
We honor the vibrant LGBTQ+ community both within ANI Pharmaceuticals, Inc. and across the globe. Pride Month serves as a potent reminder of the ongoing journey towards acceptance, inclusion, and equality for all. At ANI, we're committed to fostering an environment where every individual can authentically be themselves. Our strength lies in the diverse perspectives and experiences each brings to organizations. This strength fuels innovation and enhances our ability to make a meaningful impact. To all our allies: your support is invaluable in creating an inclusive workplace. Together, we're building a company culture that goes beyond acceptance to celebrate our differences, acknowledging that our diverse perspectives have the power to propel us forward on our purpose of ‘Serving Patients, Improving Lives’.
-
In a move to further strengthen ANI’s Rare Disease business, we announced today that we have signed a definitive agreement to acquire Alimera Sciences. This acquisition aligns with our growth strategy, further strengthening our Rare Disease business as the largest driver of future growth and expanding our presence in ophthalmology. The acquisition of Alimera adds two durable commercial assets with significant growth potential. For details, including webcast replay information from this morning’s call with ANI leadership, read our full press release on the ANI website. #ANIP #raredisease #pharmamergers #ophthalmology
-
This Certified Nursing Assistants Week, we join the industry in honoring the dedicated #nursingassistants who go above and beyond for patients in need. CNAs play a crucial role on healthcare teams – offering compassionate assistance with daily activities, maintaining a safe environment, and providing comfort during life’s most vulnerable moments. ANI is proud to stand with you and support the vital work that you do – this week and always. #ANIP #CNAweek
-
Please join us in congratulating ANI CEO Nikhil Lalwani, who is an Entrepreneur Of The Year® 2024 New Jersey Award winner! With this award, Nikhil joins an esteemed multi-industry community of entrepreneurs who have driven their companies’ success, transformed their industries, and made a positive impact on their employees and communities. Thank you EY for recognizing Nikhil for outstanding entrepreneurial leadership, driving impressive growth, and patient impact! #EOYUS #EOYNJ #ANIP #servingpatients #improvinglives
-
ANI’s Chief Executive Officer Nikhil Lalwani will present at the 2024 Jefferies Global Healthcare Conference in New York City at 3:30 ET on Wednesday, June 5, 2024. For webcast details, read our press release (linked in the comments section below). #ANIP #investors #pharmaceuticals